Credential Qtrade Securities’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $3.84M | Buy |
29,887
+543
| +2% | +$69.7K | 0.21% | 62 |
|
|
2023
Q4 | $3.04M | Sell |
29,344
-2,564
| -8% | -$265K | 0.18% | 68 |
|
|
2023
Q3 | $2.9M | Buy |
31,908
+874
| +3% | +$79.5K | 0.19% | 68 |
|
|
2023
Q2 | $2.51M | Buy |
31,034
+2,626
| +9% | +$212K | 0.16% | 75 |
|
|
2023
Q1 | $2.26M | Buy |
28,408
+66
| +0.2% | +$5.25K | 0.15% | 77 |
|
|
2022
Q4 | $1.92M | Buy |
28,342
+1,110
| +4% | +$75.1K | 0.14% | 82 |
|
|
2022
Q3 | $1.36M | Buy |
27,232
+684
| +3% | +$34.1K | 0.11% | 100 |
|
|
2022
Q2 | $1.48M | Buy |
26,548
+1,594
| +6% | +$88.8K | 0.11% | 96 |
|
|
2022
Q1 | $1.39M | Buy |
24,954
+2,256
| +10% | +$125K | 0.09% | 107 |
|
|
2021
Q4 | $1.27M | Buy |
22,698
+362
| +2% | +$20.3K | 0.09% | 110 |
|
|
2021
Q3 | $1.07M | Buy |
22,336
+4,838
| +28% | +$232K | 0.08% | 112 |
|
|
2021
Q2 | $733K | Buy |
17,498
+416
| +2% | +$17.4K | 0.06% | 145 |
|
|
2021
Q1 | $576K | Buy |
17,082
+136
| +0.8% | +$4.59K | 0.05% | 146 |
|
|
2020
Q4 | $592K | Sell |
16,946
-90
| -0.5% | -$3.14K | 0.06% | 129 |
|
|
2020
Q3 | $591K | Sell |
17,036
-270
| -2% | -$9.37K | 0.07% | 124 |
|
|
2020
Q2 | $567K | Buy |
17,306
+798
| +5% | +$26.1K | 0.07% | 123 |
|
|
2020
Q1 | $497K | Buy |
+16,508
| New | +$497K | 0.08% | 114 |
|
|
2019
Q3 | – | Sell |
-116
| Closed | -$2.96K | – | 296 |
|
|
2019
Q2 | $2.96K | Buy |
+116
| New | +$2.96K | ﹤0.01% | 277 |
|
|
2018
Q4 | – | Sell |
-18,640
| Closed | -$439K | – | 284 |
|
|
2018
Q3 | $439K | Buy |
+18,640
| New | +$439K | 0.09% | 124 |
|